Phase II Trial of Platinum-Etoposide Chemotherapy & Durvalumab with SBRT for Small Cell Lung Cancer

Phase II Trial of Platinum-Etoposide Chemotherapy & Durvalumab with SBRT for Small Cell Lung CancerПодробнее

CeLEBrATE: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage SCLCПодробнее

Updated results from the CASPIAN trial of durvalumab plus chemo in SCLCПодробнее

A Study of Chemotherapy With Durvalumab and Tremelimumab in NSCLCПодробнее

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-sta...Подробнее

Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...Подробнее

Dr. Bazhenova on the PACIFIC Trial With Durvalumab in NSCLCПодробнее

Double immunotherapy with durvalumab and tremelimumab versus quadruple therapy in NSCLCПодробнее

A Randomized Phase 2 Trial of Durvalumab With or Without SBRT in Non-Small Cell Lung CancerПодробнее

CASPIAN Trial: Durvalumab and Chemotherapy in ES-SCLCПодробнее

PACIFIC trial updates: durvalumab after chemotherapy in NSCLCПодробнее

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for ch...Подробнее

PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLCПодробнее

[lung]The role of durvalumab in patients with stage 3 lung cancer in a real hospitalПодробнее

Extensive-Stage SCLC: Potential in the CASPIAN TrialПодробнее

Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary ResultsПодробнее

Durvalumab improves PFS in stage III lung cancerПодробнее

Phase III real-world PACIFIC-R trial for NSCLCПодробнее

Expert comment: CASPIAN trial of durvalumab in SCLC | Raffaele CalifanoПодробнее

PACIFIC 6: durvalumab after sCRT in patients with NSCLCПодробнее